AGL 5.75 Increased By ▲ 0.05 (0.88%)
ANL 8.90 Decreased By ▼ -0.20 (-2.2%)
AVN 79.40 Increased By ▲ 0.24 (0.3%)
BOP 5.16 Decreased By ▼ -0.05 (-0.96%)
CNERGY 4.69 Decreased By ▼ -0.04 (-0.85%)
EFERT 81.48 Increased By ▲ 0.37 (0.46%)
EPCL 51.00 Increased By ▲ 0.25 (0.49%)
FCCL 13.48 Decreased By ▼ -0.04 (-0.3%)
FFL 5.80 Increased By ▲ 0.04 (0.69%)
FLYNG 7.17 Decreased By ▼ -0.12 (-1.65%)
FNEL 4.78 Decreased By ▼ -0.06 (-1.24%)
GGGL 8.80 Decreased By ▼ -0.09 (-1.01%)
GGL 15.75 Decreased By ▼ -0.05 (-0.32%)
HUMNL 5.82 Decreased By ▼ -0.01 (-0.17%)
KEL 2.57 Decreased By ▼ -0.02 (-0.77%)
LOTCHEM 29.30 Decreased By ▼ -0.50 (-1.68%)
MLCF 25.35 Increased By ▲ 0.20 (0.8%)
OGDC 72.60 Decreased By ▼ -0.10 (-0.14%)
PAEL 15.41 Decreased By ▼ -0.06 (-0.39%)
PIBTL 5.16 Increased By ▲ 0.03 (0.58%)
PRL 16.30 Decreased By ▼ -0.20 (-1.21%)
SILK 1.05 Decreased By ▼ -0.05 (-4.55%)
TELE 9.34 Decreased By ▼ -0.21 (-2.2%)
TPL 7.29 Decreased By ▼ -0.04 (-0.55%)
TPLP 19.14 Decreased By ▼ -0.12 (-0.62%)
TREET 21.86 Increased By ▲ 0.02 (0.09%)
TRG 142.70 Decreased By ▼ -1.40 (-0.97%)
UNITY 17.20 Decreased By ▼ -0.32 (-1.83%)
WAVES 10.05 Increased By ▲ 0.05 (0.5%)
WTL 1.37 No Change ▼ 0.00 (0%)
BR100 4,247 Decreased By -11.4 (-0.27%)
BR30 15,761 Decreased By -80.7 (-0.51%)
KSE100 42,341 Decreased By -32.4 (-0.08%)
KSE30 15,638 Decreased By -27 (-0.17%)
Pakistan

DRAP approves Sinopharm vaccine for people above 60 years

  • NCOC states that the Sinopharm vaccine is being administered to people up to the age of 60 years, however, it would now be used to inoculate citizens above 60 years of age too
  • On February 2, the first batch of 500,000 doses of Sinopharm vaccine arrived in Pakistan as a gift from China
Published March 5, 2021
Follow us

(Karachi) The Drug Regulatory Authority of Pakistan (DRAP) has approved Sinopharm coronavirus vaccine for people above 60 years of age, local media reported on Friday.

As per the National Command and Control Centre (NCOC), the Sinopharm vaccine is being administered to people up to the age of 60 years, however, it would now be used to inoculate citizens above 60 years of age too.

DRAP has approved China’s Sinopharm coronavirus vaccine for inoculations to registered health workers over 60 years.

Earlier, Special Assistant to the Prime Minister (SAPM) on National Health Services, Dr Faisal Sultan said the Chinese made Covid-19 vaccine, Sinopharm, is not recommended for the people above 60 years of age.

He said that based on the findings of expert committee’s preliminary analysis of Sinopharm data, the government has recommended the vaccine be licensed for people aged 18-60, at this stage.

On February 2, the first batch of 500,000 doses of Sinopharm vaccine arrived in Pakistan as a gift from China to be used to inoculate the frontline health workers to protect them from COVID-19 at initial stage.

Foreign Minister Qureshi said that the vaccine had arrived right at the time when Pakistan was grappling with the second wave of COVID-19. He said that Pakistan-China cooperation in fighting the pandemic, since its outbreak, has been exemplary.

Comments

Comments are closed.

DRAP approves Sinopharm vaccine for people above 60 years

Intra-day update: rupee records marginal loss against US dollar

Punjab local government election to be held in April: ECP

Islamic banking crucial aspect of Pakistan's financial sector: SBP Governor

Azam Nazeer Tarar takes charge as law minister again

PM tells Jefferies Group team: Steps taken to stabilise economy

ECC approves Kissan Package: Power tariff for tubewells reduced to Rs13 per unit

Former China leader Jiang Zemin dead: state media

Sri Lanka’s debt to China close to 20% of public external debt

OPEC+ decision to hold virtual meeting signals little likelihood of policy change

Stomach bug sweeps through England camp on eve of Pakistan Test